Felderbauer P, Hoffmann P, Klein W, Bulut K, Ansorge N, Epplen J T, Schmitz F, Schmidt W E
Department of Internal Medicine I, St. Josef Hospital, Ruhr-University of Bochum, Germany.
Exp Clin Endocrinol Diabetes. 2005 Jan;113(1):31-4. doi: 10.1055/s-2004-830523.
Calcium-sensing receptor gene (CASR) mutations that alter the function of the G protein coupled Ca (2+)-sensing receptor are reported in patients with familial hypocalciuric hypercalcemia (FHH), autosomal dominant hypocalcemia (ADH), and neonatal severe hyperparathyroidism (NSHPT). In search for novel disease causing mutations in the CASR gene, we screened exons 2 - 7 of the CASR gene of a family with FHH using single-strand conformation polymorphism analysis. We identified a novel CASR mutation (c.518 T > C; L173 P) in exon 4 encoding for the extracellular domain of the Ca (2+)-sensing receptor. This region seems to represent a hot spot within the CASR gene with at least 13 reported disease causing mutations thus far.
据报道,在家族性低钙血症性高钙血症(FHH)、常染色体显性低钙血症(ADH)和新生儿重症甲状旁腺功能亢进症(NSHPT)患者中,存在改变G蛋白偶联钙离子(Ca2+)敏感受体功能的钙敏感受体基因(CASR)突变。为了寻找CASR基因中导致疾病的新突变,我们使用单链构象多态性分析,对一个FHH家族的CASR基因外显子2至7进行了筛查。我们在编码Ca(2+)敏感受体细胞外结构域的外显子4中鉴定出一个新的CASR突变(c.518 T>C;L173P)。该区域似乎是CASR基因内的一个热点,迄今为止至少有13个已报道的致病突变。